AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 132 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,269 | -16.7% | 16,903 | -33.2% | 0.00% | – |
| Q2 2023 | $23,136 | -70.1% | 25,285 | -81.7% | 0.00% | -100.0% |
| Q1 2023 | $77,356 | +60.0% | 138,037 | +64.8% | 0.00% | +100.0% |
| Q4 2022 | $48,334 | +504.2% | 83,768 | +220.5% | 0.00% | – |
| Q3 2022 | $8,000 | -38.5% | 26,134 | -26.6% | 0.00% | – |
| Q2 2022 | $13,000 | -43.5% | 35,599 | +10.7% | 0.00% | -100.0% |
| Q1 2022 | $23,000 | -68.9% | 32,169 | -2.3% | 0.00% | -66.7% |
| Q4 2021 | $74,000 | +19.4% | 32,911 | +54.1% | 0.00% | +50.0% |
| Q3 2021 | $62,000 | +29.2% | 21,361 | +52.1% | 0.00% | -33.3% |
| Q1 2021 | $48,000 | -75.3% | 14,046 | -54.2% | 0.00% | +200.0% |
| Q4 2019 | $194,000 | +240.4% | 30,694 | +198.4% | 0.00% | 0.0% |
| Q4 2018 | $57,000 | – | 10,285 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |